913 Translational analysis of advanced metastatic bladder cancer patients treated with IO combination maveropepimut-S, cyclophosphamide, and pembrolizumab | Zendy

AI Assistant Blog Pricing

913 Translational analysis of advanced metastatic bladder cancer patients treated with IO combination maveropepimut-S, cyclophosphamide, and pembrolizumab

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.